Novartis (NVS) Enters $1.7 Billion Development Deal, Says Report [Yahoo! Finance]
Novartis AG (NVS)
Last novartis ag earnings: 4/28 01:00 am
Check Earnings Report
US:NYSE Investor Relations:
novartis.com/investors
Company Research
Source: Yahoo! Finance
Swiss pharmaceutical giant Novartis AG (NYSE:NVS) has entered into a massive $1.7 billion partnership with British pharmaceutical firm Relation Therapeutics to develop treatments for allergic diseases, according to a report from Bloomberg which surfaced on December 9th. Through this deal, the firm will use Relation's AI platform to develop new drugs by studying the genetics involved in diseases. A day earlier, Novartis AG (NYSE:NVS)'s shares were upgraded to Overweight from Neutral by investment bank JPMorgan. As part of its coverage, the bank also raised the firm's share price target to CHF125 from an earlier CHF95 as it based its optimism on the back of positive sentiment regarding the firm's outlook for 2026.nNovartis AG (NYSE:NVS) has been busy with partnerships in 2025 as its deal with Relation isn't the only one that it has inked. For instance, the firm bought Avidity Biosciences for a whopping $12 billion price tag in October. Through the deal, Novartis AG (NYSE:NVS) aims to
Show less
Read more
Impact Snapshot
Event Time:
NVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVS alerts
High impacting Novartis AG news events
Weekly update
A roundup of the hottest topics
NVS
News
- Novartis breaks ground on flagship manufacturing hub in North Carolina [Yahoo! Finance]Yahoo! Finance
- Novartis breaks ground on flagship manufacturing hub in North CarolinaGlobeNewswire
- Drugmaker Novartis begins work on Research Triangle expansion [Yahoo! Finance]Yahoo! Finance
- Biopharmaceutical Contract Manufacturing Market to Surpass US$ 100 Billion by 2031 [Yahoo! Finance]Yahoo! Finance
- Sen-Jam Pharmaceutical Secures Major Strategic Partnership with TASK Clinical to Fund Two-Thirds of Phase 3 Trial for SJP-001 [Yahoo! Finance]Yahoo! Finance
NVS
Earnings
- 10/28/25 - Miss
NVS
Sec Filings
- 11/25/25 - Form 6-K
- 11/20/25 - Form 6-K
- 11/5/25 - Form 6-K
- NVS's page on the SEC website